Source: Annual Congress 2002 - Asthma - aspects relevant to everyday practice
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. P. Walker, L. Davies, P. M. A. Calverley (Liverpool, United Kingdom). Use and safety of histamine challenge testing in clinical practice. Eur Respir J 2002; 20: Suppl. 38, 2615

Member's Comments

No comment yet.

Related content which might interest you: Usefulness of mannitol challenge testing for diagnosing asthma in everyday clinical practice Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018 Use and misuse of clinical and evidence-based guidelines in clinical practice Source: Annual Congress 2009 - Physiotherapy for the respiratory patient: evidence-based guidelines Year: 2009 Recommendations on the use of exercise testing in clinical practice Source: Guideline 2007 Year: 2007 Recommendations on the use of exercise testing in clinical practice Source: Eur Respir J 2007; 29: 1064-1066 Year: 2007 Mannitol challenge testing in clinical practice and its role in identifying aiways hyperreactivity Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases Year: 2012 Exercise testing for the evaluation of pharmacological interventions in clinical practice Source: Annual Congress 2013 –PG14 Cardiopulmonary exercise testing in the evaluation of patients with respiratory diseases Year: 2013 Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement Source: Eur Respir J 2016; 47: 429-460 Year: 2016 Usefulness in clinical practice Source: Annual Congress 2009 - Asthma control: monitoring tool or goal? Validity in children and adults Year: 2009 Indication, interpretation and clinical utility of bronchoprovocation testing Source: Annual Congress 2012 - New ATS/ERS recommendations for bronchoprovocation challenge testing Year: 2012 Improving the appropriate use of Mannitol challenge testing in a large teaching hospital. Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021 Are the guideline recommendations for laboratory testing of exercise- induced bronchoconstriction useful? Source: Eur Respir J 2007; 30: Suppl. 51, 702s Year: 2007 Efficacy and safety of omalizumab in real-life practice in India Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012 Improvement patient safety during lung function testing through the implementation of a safety checklist Source: Virtual Congress 2020 – Lung function diagnostics Year: 2020 Clinical efficacy and safety of medical thoracoscopy Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Use of Omalizumab in children in real clinical practice. Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 Safety of sputum induction in asthmatics in clinical practice Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010 Exercise testing for the evaluation of interventions in clinical practice and trials Source: Annual Congress 2010 - PG18 Postgraduate Course: Cardiopulmonary exercise testing in the evaluation of the respiratory patient Year: 2010 The utility and choice of exercise testing in the evaluation of the efficacy of pulmonary rehabilitation Source: ERS Course 2017 Year: 2017 Feasibility and safety of a dosimetric bronchial challenge test for infants Source: Eur Respir J 2005; 26: Suppl. 49, 675s Year: 2005